BACKGROUND: @entity1 with hepatic metastases often develop obstruction of the intrahepatic inferior vena cava (IVC), known as @entity6323 . This obstruction is debilitating due to the development of @entity843 and @entity4 . OBJECTIVES: To update our experience in the diagnosis and treatment of @entity6323 and to evaluate the efficacy of expandable stents in the treatment of @entity6323 . DESIGN: Retrospective review. SETTING: University hospital. @entity1 : Twenty-eight @entity1 with hepatic metastases diagnosed as @entity6323 . INTERVENTION: @entity1 underwent transfemoral placement of Gianturco-Rosch self-expandable Z metallic stents in the intrahepatic IVC. One @entity1 was treated with a Wallstent. Stents were 15 to 25 mm in diameter and 60 to 140 mm in length. Pressure gradients across the IVC were measured before and after stent placement in all @entity1 . MAIN OUTCOME MEASURES: Change in pressure gradient, relief of @entity843 and @entity4 , loss of weight, patency of the primary stent, and survival after stent placement. RESULTS: Pressure gradients were reduced in all @entity1 , which was followed by rapid reduction of @entity843 and @entity4 with a median weight loss of 5.85 kg. Survival after stent placement varied from 1 to 99 days, with a mean of 34 days. Stent patency remained until death in all @entity1 . CONCLUSION: The debilitation of @entity6323 due to @entity843 and @entity4 can be considerably palliated by placement of transfemoral percutaneous stents.

Results of treatment of XXXX with expandable metallic stents.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'PATIENTS'] @entity4 :: ('MESH:D004487', 'Disease') :: ['anasarca'] @entity843 :: ('MESH:D001201', 'Disease') :: ['ascites'] @entity6323 :: ('MESH:C563013', 'Disease') :: ['IVC syndrome', 'having IVC syndrome']
@entity6323 :: (MESH:C563013,Disease) :: ['inferior vena cava syndrome']
